StockData
Summit Therapeutics Inc. logo

Summit Therapeutics Inc. (SMMT) stock

SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$10.67−1.15 (-9.73%)

Close on Nov 17, 2026Market cap $8.51BP/E –Yield –

Summit Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Summit Therapeutics's EV/EBITDA was 25.0× on Jan 31, 2022, against 15.7× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202225.0×−8.9
2021Dec 31, 202133.8×+25.4
2020Dec 31, 20208.5×–

More Summit Therapeutics figures

See a number that looks wrong?